The phosphorylated prodrug FTY720 is a histone deacetylase Q15 inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer
Ontology highlight
ABSTRACT: Nuclear FTY720-P is a potent inhibitor of class I histone deacetylases (HDACs) that enhances histone acetylations and regulates expression of a restricted set of genes independently of its known effects on canonical signaling through sphingosine-1-phosphate (S1P) receptors. We found that FTY720 is phosphorylated in Era-negative breast cancer cells by nuclear sphingosine kinase 2 and accumulates these cells.
ORGANISM(S): Homo sapiens
PROVIDER: GSE69462 | GEO | 2015/06/03
SECONDARY ACCESSION(S): PRJNA285668
REPOSITORIES: GEO
ACCESS DATA